Last reviewed · How we verify

NCT04486612: IJV

Ultrasonographic Measurement of Internal Jugular Vein as a Predictor of Hypotension Following Spinal Anesthesia

Completed Last updated 3 February 2021
What this trial tests

trial testing spinal anesthesia in Spinal Anesthetics Causing Adverse Effects in Therapeutic Use in 47 participants. Completed in 24 September 2020.

Timeline
1 January 2020
Primary endpoint
24 September 2020
24 September 2020

Quick facts

Lead sponsorEskisehir Osmangazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment47
Start date1 January 2020
Primary completion24 September 2020
Estimated completion24 September 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Eskisehir Osmangazi University

Who can join

Adults 18 to 65, any sex, with Spinal Anesthetics Causing Adverse Effects in Therapeutic Use or Hypotension Postprocedural. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypotension after spinal anesthesia is associated with significant perioperative morbidity and mortality, especially in hypovolemic patients. Ultrasonographic measurement of internal jugular vein (IJV) has been recently shown as effective in predicting the intravascular volume status. The aim was to investigate the reliability of preanesthetic ultrasound measurements of IJV in predicting hypotension after spinal anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of spinal anesthesia

Trials testing the same drug.

Other Eskisehir Osmangazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04486612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing